Skip to main content

Solace Health raises $130M bringing it to unicorn status

The California-based company will use the funds to expand its healthcare advocate network and platform, partnerships with payers and providers and for clinical research.
By Jessica Hagen , Executive Editor
Patient in a chair with a healthcare provider standing next to them

Photo: Halfpoint Images/Getty Images

Solace Health, a healthcare navigation platform, announced it scored $130 million in Series C funding, bringing its valuation to over $1 billion. 

IVP led the round, with participation from Menlo Ventures, SignalFire, Torch Capital, Inspired Capital and RiverPark Ventures. 

WHAT IT DOES

Solace matches patients with expert advocates via phone, text or email, who help them navigate their healthcare journey, whether through receiving a new diagnosis, finding a doctor, coordinating care, receiving approvals or taking control of a chronic illness. 

The advocates are covered by Medicare, most Medicare Advantage plans and some health insurance carriers. 

The California-based company also allows providers to refer their patients to Solace health advocates and offers its own EHR for advocates to update and access patient medical records to help with the navigation process. 

Solace will use the funds to expand its network of advocates for Medicare and Medicare Advantage members, enhance its platform and perform clinical research. It says it will also expand its partnerships with payers and providers to provide advocacy to patients earlier in their care journey. 

“IVP understands how to scale companies where execution and consequences are inseparable," Jeremy Gurewitz, CEO and cofounder of Solace, said in a statement. "This partnership allows us to embed advocacy earlier in care, at national scale, and establish it as a permanent part of how healthcare works in the United States.

MARKET SNAPSHOT

Solace secured $60 million in Series B funding in 2025, one year after securing $14 million in Series A funding.

Another company in the patient advocacy space is Citizen Health, which works with patients with rare diseases. 

The company raised $30 million in Series A funding last year, bringing its total funding to $44 million since its launch in 2023. At the time, the company announced it plans to launch the first version of its AI advocate tool.

Citizen Health raised $14.5 million in seed funding in 2024.